UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.69 +0.67 (+0.86%) GOLD FUTURES
2,391.20 +31.30 (+1.33%) DOW
39,827.03 +268.92 (+0.68%) Bitcoin GBP
51,672.67 +3,296.88 (+6.82%)
Neurocrine Biosciences, Inc. (NBIX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:45PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 13.94B |
| Enterprise value | 13.24B |
| Trailing P/E | 37.63 |
| Forward P/E | 28.09 |
| PEG ratio (5-yr expected) | 0.48 |
| Price/sales (ttm) | 7.17 |
| Price/book (mrq) | 5.84 |
| Enterprise value/revenue | 6.68 |
| Enterprise value/EBITDA | 26.63 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.28 |
| 52-week change 3 | 45.36% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 148.37 |
| 52-week low 3 | 89.04 |
| 50-day moving average 3 | 138.09 |
| 200-day moving average 3 | 123.84 |
Share statistics
| Avg vol (3-month) 3 | 852.32k |
| Avg vol (10-day) 3 | 742.6k |
| Shares outstanding 5 | 100.64M |
| Implied shares outstanding 6 | 100.64M |
| Float 8 | 99.41M |
| % held by insiders 1 | 1.00% |
| % held by institutions 1 | 95.84% |
| Shares short (30 Apr 2024) 4 | 1.83M |
| Short ratio (30 Apr 2024) 4 | 2.37 |
| Short % of float (30 Apr 2024) 4 | 2.13% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.82% |
| Shares short (prior month 28 Mar 2024) 4 | 2.43M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 29 Dec 1995 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 18.65% |
| Operating margin (ttm) | 20.43% |
Management effectiveness
| Return on assets (ttm) | 10.08% |
| Return on equity (ttm) | 18.16% |
Income statement
| Revenue (ttm) | 1.98B |
| Revenue per share (ttm) | 20.15 |
| Quarterly revenue growth (yoy) | 22.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 492.9M |
| Net income avi to common (ttm) | 369.7M |
| Diluted EPS (ttm) | 3.68 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.21B |
| Total cash per share (mrq) | 12.03 |
| Total debt (mrq) | 410.7M |
| Total debt/equity (mrq) | 17.21% |
| Current ratio (mrq) | 2.52 |
| Book value per share (mrq) | 23.72 |
Cash flow statement
| Operating cash flow (ttm) | 645.4M |
| Levered free cash flow (ttm) | 719.32M |
© 2024 Yahoo. All rights reserved.